Rare-disease enzyme and gene therapies
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Howard Marks / Oaktree | 69 | Added +299% | 167,955,000 | $162,072,378 | 0.8% |
| INVESTOR AB (auto-surfaced) | 15 | Holds (flat) | 3,700 | $209,013 | 0.0% |
| Bridgewater | 49 | Trimmed -10% | 206,911 | $11,688,402 | 0.1% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-06-27.